Matrisome Bio, Inc.
Cambridge, MA Doing business as Matrisome Bio Inc.
- UEI
- DWR8LNQUCJR8
- CAGE
- 07E56
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 700 Main St, Cambridge, MA 02139, USA
- Website
- matrisomebio.com
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of an extracellular matrix-targeted theranostic radiopharmaceutical for metastatic lung cancer - project… | National Cancer Institute | $3,481,203 | |
| Novel theranostic radioligands targeting disease-specific extracellular matrix components specific to tumor and… | National Cancer Institute | $299,496 |
Quick answers
What is Matrisome Bio, Inc.'s UEI?
Matrisome Bio, Inc.'s Unique Entity ID (UEI) in SAM.gov is DWR8LNQUCJR8.
What is Matrisome Bio, Inc.'s CAGE code?
Matrisome Bio, Inc.'s CAGE code is 07E56.
What is Matrisome Bio, Inc.'s primary NAICS code?
Matrisome Bio, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Matrisome Bio, Inc. located?
Matrisome Bio, Inc.'s physical address in SAM.gov is 700 Main St, Cambridge, MA 02139, USA.
Is Matrisome Bio, Inc. registered in SAM.gov?
Yes. Matrisome Bio, Inc.'s SAM.gov registration is active through July 24, 2027.
What is Matrisome Bio, Inc.'s most recent federal award?
Matrisome Bio, Inc.'s most recent federal grant award is Development of an extracellular matrix-targeted theranostic radiopharmaceutical for metastatic lung cancer - project… (R44CA298532), from National Cancer Institute, on September 23, 2025.
On GovTribe
See Matrisome Bio, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors